D
Dong Wan Kim
Researcher at Seoul National University Hospital
Publications - 880
Citations - 61091
Dong Wan Kim is an academic researcher from Seoul National University Hospital. The author has contributed to research in topics: Lung cancer & Crizotinib. The author has an hindex of 89, co-authored 833 publications receiving 49632 citations. Previous affiliations of Dong Wan Kim include University of California, Irvine & Korea University.
Papers
More filters
Journal ArticleDOI
Activity and safety of AZD3759 in EGFR-mutant non-small-cell lung cancer with CNS metastases (BLOOM): a phase 1, open-label, dose-escalation and dose-expansion study.
Myung-Ju Ahn,Dong Wan Kim,Byoung Chul Cho,Sang We Kim,Jong Seok Lee,Jin Seok Ahn,Tae Min Kim,Chia-Chi Lin,Hye Ryun Kim,Thomas John,Steven Kao,Jonathan W. Goldman,Wu Chou Su,Ronald B. Natale,Sarit Rabbie,Bryony Harrop,Philip Overend,Zhenfan Yang,James Chih-Hsin Yang +18 more
TL;DR: AZD3759 at a dose of 200 mg twice daily showed a tolerable safety profile in patients with NSCLC, with severity of adverse events assessed with the National Cancer Institute's Common Terminology Criteria for Adverse Events, version 4.03.
Journal ArticleDOI
ERCC1 expression by immunohistochemistry and EGFR mutations in resected non-small cell lung cancer
Kyung-Hun Lee,Hye Sook Min,Sae-Won Han,Do-Youn Oh,Do-Youn Oh,Se-Hoon Lee,Se-Hoon Lee,Dong Wan Kim,Dong Wan Kim,Seock-Ah Im,Seock-Ah Im,Doo Hyun Chung,Doo Hyun Chung,Young Tae Kim,Tae-You Kim,Tae-You Kim,Dae Seog Heo,Dae Seog Heo,Yung-Jue Bang,Yung-Jue Bang,Sook Whan Sung,Joohyun Kim +21 more
TL;DR: ERCC1 expression was identified as a positive prognostic marker in resected NSCLC, and EGFR mutations were more frequently found in ERCC1-negative tumors.
Journal ArticleDOI
Comparison of intrathecal chemotherapy for leptomeningeal carcinomatosis of a solid tumor: methotrexate alone versus methotrexate in combination with cytosine arabinoside and hydrocortisone.
Dae-Young Kim,Keun Wook Lee,Tak Yun,Sook Ryun Park,Jooyoung Jung,Dong Wan Kim,Tae-You Kim,Dae Seog Heo,Yung-Jue Bang,Noe Kyeong Kim +9 more
TL;DR: Combination intrathecal chemotherapy with methotrexate, cytosine arabinoside and hydrocortisone showed more favorable effects than methotRexate single therapy for leptomeningeal carcinomatosis in solid tumors.
Journal ArticleDOI
Lazertinib in patients with EGFR mutation-positive advanced non-small-cell lung cancer: results from the dose escalation and dose expansion parts of a first-in-human, open-label, multicentre, phase 1–2 study
Myung-Ju Ahn,Ji Youn Han,Ki Hyeong Lee,Sang We Kim,Dong Wan Kim,Yun Gyoo Lee,Eun Kyung Cho,Joo Hang Kim,Gyeong Won Lee,Jong Seok Lee,Young Joo Min,Jin Soo Kim,Sung Sook Lee,Hye Ryun Kim,Min Hee Hong,Jin Seok Ahn,Jong Mu Sun,Heung Tae Kim,Dae Ho Lee,Sohee Kim,Byoung Chul Cho +20 more
TL;DR: Lazertinib had a tolerable safety profile and showed promosing clinical activity in patients with NSCLC progressing on or after EGFR TKI therapy, and the findings provide a rationale for further clinical investigations.
Journal ArticleDOI
Preparation of Brookite‐Type TiO2/Carbon Nanocomposite Electrodes for Application to Li Ion Batteries
TL;DR: In this article, a simple synthesis of nanocrystalline brookite-type TiO2 using titanium trichloride (TiCl3) and urea [(NH2)2CO] was reported.